ArticleHand (New York, N.Y.)2026
Preoperative Corticosteroid Injection and Postoperative Infection Following De Quervain's Release: A National Database Analysis.
Article in Hand (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDe Quervain's tenosynovitis is initially treated with analgesics, immobilization, and corticosteroid injections. Patients with symptoms refractory to corticosteroid injection may require surgical release. No prior studies have identified whether injection of corticosteroid for De Quervain's tenosynovitis leads to adverse postoperative outcomes. This study aimed to determine whether corticosteroid injections administered within 3 months prior to De Quervain's release increase the risk of postoperative surgical site infection.
methodsWe used a national administrative database to identify adult patients undergoing De Quervain's release and divided patients into two cohorts based on whether they received a corticosteroid injection for De Quervain's tenosynovitis within 90 days prior to the surgery. After propensity score matching for age, sex, US region, insurance plan, Elixhauser Comorbidity Index, and history of tobacco use, rates of surgical site infection, reoperation, and wound dehiscence were assessed.
resultsPatients who received an injection within the 90-day period prior to surgical release did not experience a higher incidence of surgical site infections, return to the operating room for infection, or wound dehiscence. An additional sensitivity analysis assessing the risk of injection within 60 days before surgery showed no increased risk of postoperative surgical site infection.
conclusionsInjection of corticosteroids within 60 or 90 days prior to surgical release for De Quervain's tenosynovitis was not associated with increased risk of postoperative surgical site infection or return to the operating room to treat infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.